Health ❯ Healthcare ❯ Patient Care

Quality of Life

Treatment Outcomes Chronic Illness Management Treatment Side Effects Chronic Conditions Symptom Management Treatment Efficacy Survival Rates Chronic Illness Treatment Options Patient Experiences

3 ARTICLES

last mo.

Penn Launches First U.S. Pilot Trial of Conformal FLASH Proton Therapy

This Phase I study tests whether five ultra‑fast treatments can spare healthy tissue by shortening the time patients spend receiving radiation for recurrent head and neck cancer.

6 ARTICLES

last mo.

Aficamten Improves Symptoms and Exercise Capacity in Nonobstructive HCM

8 ARTICLES

last mo.

FDA Approves Lisraya as First Oral Treatment for Adult Dermatomyositis

3 ARTICLES

2mo ago

UC Irvine Proposes Mitochondrial‑Targeted, Steroid‑Sparing Strategy for CAR T Neurotoxicity

5 ARTICLES

4mo ago

Six Regions Start Paying Spain’s New ELA Benefits as Many Families Face Financial Barriers

4 ARTICLES

4mo ago

Daraxonrasib Nearly Doubles Median Survival in Previously Treated Metastatic Pancreatic Cancer

35 ARTICLES

4mo ago

Daraxonrasib Doubles Survival in Treated Metastatic Pancreatic Cancer in Phase 3 Trial

6 ARTICLES

4mo ago

Daraxonrasib Doubles Survival in Second‑Line Metastatic Pancreatic Cancer

4 ARTICLES

5mo ago

Peru Uses National Donor Day to Spotlight Critical Shortage of Organ Donors

3 ARTICLES

5mo ago

Two-Session MRI-Guided Radiotherapy Matches Five Visits on Side Effects in Small Prostate Cancer Trial

4 ARTICLES

5mo ago

AIIMS Delhi Performs First Pancreas–Kidney Transplant in 18 Years

3 ARTICLES

5mo ago

FDA Clears All-Oral Decitabine/Cedazuridine Plus Venetoclax for Older AML Patients

5 ARTICLES

5mo ago

NIHR Backs UK Trial Testing Two Cochlear Implants for Adults

3 ARTICLES

5mo ago

Pfizer’s Elrexfio Posts Phase 3 PFS Win Over Standard Multiple Myeloma Regimen

4 ARTICLES

6mo ago

Low-Dose Nivolumab Injections Shrink High-Risk Oral Precancers in Early Trial

3 ARTICLES

6mo ago

Xenon Presents Phase 3 Azetukalner Results and 48‑Month Data at American Academy of Neurology Meeting

Quality of Life

Penn Launches First U.S. Pilot Trial of Conformal FLASH Proton Therapy

Aficamten Improves Symptoms and Exercise Capacity in Nonobstructive HCM

FDA Approves Lisraya as First Oral Treatment for Adult Dermatomyositis

UC Irvine Proposes Mitochondrial‑Targeted, Steroid‑Sparing Strategy for CAR T Neurotoxicity

Six Regions Start Paying Spain’s New ELA Benefits as Many Families Face Financial Barriers

Resorbable‑Microsphere Embolization Cuts Knee Osteoarthritis Pain for a Year

Daraxonrasib Doubles Survival in Phase 3 Trial for Advanced Pancreatic Cancer

New Oral Drug Nearly Doubles Survival for Treated Metastatic Pancreatic Cancer

NHS Approves First New Ovarian Cancer Drug in 20 Years

Daraxonrasib Nearly Doubles Median Survival in Previously Treated Metastatic Pancreatic Cancer

Never miss stories about

Quality of Life

Daraxonrasib Doubles Survival in Treated Metastatic Pancreatic Cancer in Phase 3 Trial

Daraxonrasib Doubles Survival in Second‑Line Metastatic Pancreatic Cancer

Peru Uses National Donor Day to Spotlight Critical Shortage of Organ Donors

Two-Session MRI-Guided Radiotherapy Matches Five Visits on Side Effects in Small Prostate Cancer Trial

AIIMS Delhi Performs First Pancreas–Kidney Transplant in 18 Years

FDA Clears All-Oral Decitabine/Cedazuridine Plus Venetoclax for Older AML Patients

NIHR Backs UK Trial Testing Two Cochlear Implants for Adults

Pfizer’s Elrexfio Posts Phase 3 PFS Win Over Standard Multiple Myeloma Regimen

Low-Dose Nivolumab Injections Shrink High-Risk Oral Precancers in Early Trial

Xenon Presents Phase 3 Azetukalner Results and 48‑Month Data at American Academy of Neurology Meeting

Never miss stories about

Quality of Life